Snowball logo
logo
4105

TTY Biopharm Co Ltd

4105 β€’ TWO
NT$76.20-NT$0.90Β  (1.17%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
4,535.65,061.65,505.55,893.86,452.96,153.5
COGS
1,767.62,040.12,218.52,479.12,732.42,532.6
Gross Profit
2,7683,021.53,287.13,414.73,720.53,620.8
Operating Expenses & Income
Operating Income
1,113.21,426.91,444.31,393.81,704.81,663
Total Operating Expenses
1,612.31,789.61,911.64,500.14,748.14,490.5
R&D Expenses
287.6353.4310.4271.4194.3195
Selling General & Admin Expenses
403413.3425.41,749.61,821.31,762.8
Earnings from Continuing Operations
Interest Expense
(18.98)(23.15)(35.36)(38.74)(38.66)(34.16)
Interest Income
6.30931.1780.285.7675.0872.26
Income Tax Expense
264.8305.2300.9---
Net Income
Net Income
831.91,094.41,128.51,449.61,559.11,422
Supplemental
EBIT
1,113.21,426.91,444.3---
EBITDA
1,280.51,613.21,645.2---
In millions of TWD, except % and values per 1 share